ANVS

$1.09+0.93%visit website

Annovis Bio, Inc.

Market Cap

$46M

Live price × SEC shares (Aug 14, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.32

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	0.00	0.00	0.00	0.00	0.00
Research & development	6,291	8,751	16,720	12,007	43,770
Total operating expenses	7,435	9,706	18,012	14,378	49,531
Operating income	(7,435)	(9,706)	(18,012)	(14,378)	(49,531)
Income tax	0.00	0.00	0.00	0.00	0.00
Net income	(7,263)	(9,834)	(17,606)	(14,821)	(49,524)
EPS (basic) ($)	(0.37)		(0.63)	(0.40)	—
EPS (diluted) ($)	(0.37)		(0.63)	(0.40)	—
Weighted avg. shares (basic)	19,685		27,848	37,519
Weighted avg. shares (diluted)	19,685		27,848	37,519

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 26 more quarters, back to Mar 2019, with Tormere Pro.

Corporate Events (8-K)

1 filing in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Oct 30, 2026 accepted 5:10 PM ET	3.01Delisting notice7.01Reg FD disclosure	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

52%

W/W +16.8pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-05-20	2026-05-21	Hoffman Michael B	Director	Purchase	76.3K	$1.87	$143K	3.36M	View
2026-04-02	2026-04-03	Hoffman Michael B	Director	Purchase	713.8K	$2.10	$1.50M	3.29M	View
2025-12-08	2025-12-08	Hoffman Michael B	Director	Purchase	45.0K	$4.31	$194K	2.57M	View
2025-11-24	2025-11-25	Hoffman Michael B	Director	Purchase	39.2K	$4.08	$160K	2.52M	View
2025-11-21	2025-11-21	Hoffman Michael B	Director	Purchase	10.0K	$3.49	$35K	2.48M	View

1–5 of 8

1 / 2

Recent News

Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE

Yahoo · 2026-10-30

Annovis Bio Obtains Noncompliance Notice From NYSE

Benzinga · 2026-10-30

Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026

Yahoo · 2026-10-29

Pfizer and Merck leaders will share a panel with Annovis’ CEO in November.

Stock Titan · 2026-10-29

Annovis to Attend the CTAD 2026 with Three Presentations

Yahoo · 2026-10-22

Parkinson's Disease Market Poised for Expansion During the Forecast Period (2026-2036) Amid JUVMO Approval and Emerging Therapeutic Innovations | DelveInsight

Yahoo · 2026-10-06

Annovis Bio (ANVS) Loses 26.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Yahoo Finance · 2026-09-08

Annovis Bio Targets March 2027 Alzheimer’s Readout, Prepares Rolling NDA

Yahoo Finance · 2026-09-03

Annovis to Host Corporate Update Webinar on September 2, 2026

Yahoo Finance · 2026-08-25

Annovis Bio stock price target reiterated at $17 by Canaccord

Investing.com · 2026-08-18

The Next Billion-Dollar Opportunity in Alzheimer's Disease Market: 6 Pipeline Therapies to Watch | DelveInsight

Yahoo Finance · 2026-08-06

ANVS|Annovis Bio Inc|Price:1.190|Chg%:+0.020

TradingKey · 2026-07-24

$ANVS stock is up 10% today. Here's what we see in our data.

Quiver Quantitative · 2026-07-08

Annovis Bio Enrolls Over 850 Patients for Its Next Alzheimer's Disease Trial

Yahoo Finance · 2026-07-07

ANVS Forecast — Price Target — Prediction for 2027

TradingView · 2026-06-26

Informational purposes only, not investment advice.

ANVS

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

Annovis Bio, Inc. (ANVS)

Reporting Insiders

Factor Profile

Corporate Events (8-K)

Date	Insider	Type	Shares	Value
2026-05-20	Hoffman Michael B	P	2,562	$4,483.5
2026-05-20	Hoffman Michael B	P	18,849	$33,928.2
2026-05-20	Hoffman Michael B	P	54,933	$104,367.21
2026-04-02	Hoffman Michael B	P	713,800	$1M
2025-12-08	Hoffman Michael B	P	30,000	$130,194